Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer's disease
- DOI
- 10.1080/14728214.2026.2693701
- Published
- 2026-06-30
- Container
- Expert Opinion on Emerging Drugs
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/14728214.2026.2693701,
title = {Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer's disease},
author = {Madia Lozupone and Vittorio Dibello and Rodolfo Sardone and Roberta Zupo and Fabio Castellana and Ilaria Bortone and Luisa Lampignano and Michela Di Matteo and Giuseppe Moramarco and Flora Dellegrazie and Antonio Daniele and Vincenzo Solfrizzi and Francesco Panza},
year = {2026},
journal = {Expert Opinion on Emerging Drugs},
doi = {10.1080/14728214.2026.2693701},
url = {https://doi.org/10.1080/14728214.2026.2693701}
}RIS
TY - JOUR TI - Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer's disease AU - Madia Lozupone AU - Vittorio Dibello AU - Rodolfo Sardone AU - Roberta Zupo AU - Fabio Castellana AU - Ilaria Bortone AU - Luisa Lampignano AU - Michela Di Matteo AU - Giuseppe Moramarco AU - Flora Dellegrazie AU - Antonio Daniele AU - Vincenzo Solfrizzi AU - Francesco Panza PY - 2026 JO - Expert Opinion on Emerging Drugs DO - 10.1080/14728214.2026.2693701 UR - https://doi.org/10.1080/14728214.2026.2693701 ER -
APA
Lozupone, M., Dibello, V., Sardone, R., Zupo, R., Castellana, F., Bortone, I., Lampignano, L., Matteo, M. D., Moramarco, G., Dellegrazie, F., Daniele, A., Solfrizzi, V., & Panza, F. (2026). Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer's disease. Expert Opinion on Emerging Drugs. https://doi.org/10.1080/14728214.2026.2693701
Source records
- crossref · retrieved 2026-09-26T06:03:04.907Z